ASCVD Risk Profile

Name : UMANG JOSHI Registration Date : 10/6/2023 8:00:56 AM

Age : 35 Years Lab Number : 451560885

Gender : Male

Y N
Previous history of Heart attack or Stroke

Y N
History of Diabetes

Y N
History of Chronic Kidney disease

Family history of premature ASCVD (History of heart

attack in father or other first-degree male relative before the Y N
age of 55 years or in mother or other first-degree female
relative before the age of 65 years)

Y N
History of High blood pressure

Y N
History of smoking and/or tobacco use
Risk estimation is based upon age, gender, blood level of cholesterol and details
provided by you

LIPID PROFILE
TEST NAME RESULTS UNIT REFERENCE RANGE

ASCVD Risk Profile

Based on the information provided you are in Low Risk category for developing Coronary Artery Disease.

For Low Risk Category, Recommended Treatment Goal/Optimal level for LDL Cholesterol is <100 mg/dL and Apo B
is <90 mg/dl*

Advise/ Follow-up recommendations:

1. Repeat Lipid Profile, Basic (B131) after 4 months**

2. Hs Troponin I*** (B110)- It is a specific marker of cardiac injury and may fine tune risk in healthy individuals

3. Lifestyle modifications such as eating a heart-healthy diet, regular aerobic exercises, maintenance of desirable body weight and avoidance of
tobacco products is recommended to lower cardiovascular disease risk

References:

*Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2020
**National Lipid Association recommendations for patient-centered management of dyslipidemia. Journal of Clinical Lipidology (2014) 8, 473–488
*** Consensus statement on the use of high-sensitivity troponin I assay for risk stratification of apparently healthy individuals – an Indian dimension. International Journal of Current
Research, Vol. 13 Issue, 01, pp.15771-15778, January, 2021

Note:
Risk estimation has been done based on conventional risk factors, presence of non-conventional risk factors (e.g. Increased Lp(a) levels, metabolic
syndrome, etc.) may re-designate you to higher risk category.
A more formal risk assessment may be used by clinicians according to their personal preferences and familiarity with the risk scores.

Disclaimer: The results and recommendations provided are intended to inform but do not replace clinical judgment.
Therapeutic options should be individualized and determined after discussion between the patient and their treating
Clinician